PART II -- OTHER INFORMATION



LEGAL PROCEEDINGS



We are presently engaged in various legal actions arising in the normal course of business.
For additional information about our material legal proceedings, please see Note 8, Commitments and Contingencies, of the accompanying notes to the consolidated financial statements.
Except as described below, there have been no material changes to the risk factors included in the Form 10-K.
The risks described here and in the Form 10-K are not the only risks we face.
44

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS



Share Repurchase Programs



The following table presents a month-to-month summary of the stock purchase activity in the first quarter of fiscal year 2020:



[DATA_TABLE_REMOVED]



1



On November 28, 2018, our Board of Directors approved a 1 million shares repurchase program expanding our capacity to repurchase shares to approximately 1.7 million shares.
We may repurchase shares from time to time in open market transactions or through privately negotiated transactions.
There is no expiration date associated with the repurchase activity.
2



"Average Price Paid per Share" reflects open market repurchases of common stock only.
3



These shares reflect the available shares authorized for repurchase under the expanded program approved by the Board on November 28, 2018.
4



Represents only shares that were tendered to us in satisfaction of employee tax withholding obligations upon the vesting of restricted stock.
45

OTHER INFORMATION



None.
EXHIBITS 



We have filed the following documents as Exhibits to this Form 10-Q/A:



[DATA_TABLE_REMOVED]



46

Plantronics, Inc.



FORM 10-Q



CROSS REFERENCE TABLE



[DATA_TABLE_REMOVED]



47
